Dr. Lamba’s News Stories

These are links to recent news stories featuring Jatinder Lamba, Ph.D., and her research lab.


Dr. Jatinder Lamba presented UF Health Cancer Center Top Influencer Award

Genetic score advances personalized treatment strategies with promising AML drug


UF College of Pharmacy trainees earn abstract achievement awards at ASH Annual Meeting

This Test May Guide AML Therapy for Black Pediatric Patients

ACS10 Score May Help Inform Treatment, Reduce Racial Disparities in Black Pediatric Patients With AML

Using patients’ genetic profile to inform AML treatment could help reduce racial disparities

Discovery may improve treatment for some leukemia patients

Dr. Jatinder Lamba receives $3.3 million NCI grant for pediatric AML research


Marrero, Marchi win abstract awards at the American Society of Hematology Annual Meeting

Celebrating Distinction ceremony recognizes endowed professors and chairs

UF-led research identifies genes involved in chemotherapy resistance in pediatric AML


UF researchers develop genetic score to improve pediatric cancer treatments

Lamba lab trainees win poster awards at UF Health Cancer Center Research Symposium

Five UF College of Pharmacy faculty appointed to endowed professorships

Dr. Jatinder Lamba awarded $1.9 million grant to continue Acute Myeloid Leukemia study

Dr. Lamba and Dr. Meshinchi from Fred Hutchinson Cancer Research Center partnered with UF’s Interdisciplinary Center for Biotechnology Research to unravel the CD33 Isoform as a novel drug target.

Dr. Jatinder Lamba featured in story about UF Research Foundation Professors


Dr. Jatinder Lamba named 2020 UF Research Foundation Professor


Dr. Jatinder Lamba receives a Live Like Bella grant to study pediatric cancer

Leukemia and Lymphoma Society awards grant to support pediatric cancer research

Dr. Jatinder Lamba’s lab receives multiple research accolades

UF Pharmacy wins four abstract awards at ASH Annual Meeting


UF researchers identify gene variant to personalize therapy for deadly form of leukemia

Bringing a leukemia treatment back to life with precision medicine

Potential biomarker for acute myeloid leukaemia therapy

CD33 Splicing Polymorphism and Response to Gemtuzumab Ozogamicin in AML


GatorX 2015

The promise of better therapy

To tailor cancer treatment: Study uses computer simulation to model patient cancer DNA

Online Publications:

CD33 directed therapy: Current and future perspective in acute myeloid leukemia (AML) (Sept. 2018)

Acute Myeloid Leukemia (AML) research and Application (April 20, 2018)

Acute Myeloid Leukemia and cytarabine pharmacogenomics (Feb 2, 2018)

Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML) (Nov.2017)

The Genetic Puzzle: Why Do We Respond to Cancer Therapy?

An interview and our research on pharmacogenomics in leukemia (Paths to Precise Prescriptions) was highlighted in International Innovations Journal.